YI 2.3 Methylglyoxal, 3-Deoxyglucosone, and Glyoxal – Precursors of Advanced Glycation Endproducts – are not Independently Associated with Indices of Carotid Stiffness: The Maastricht Study

Myrthe van der Bruggen; Marleen M.J. van Greevenbroek; Koen D. Reesink; Coen D.A. Stehouwer; Tammo Delhaas; Bart Spronck; Casper G. Schalkwijk

doi:10.2991/artres.k.201209.011

<Previous Article In Issue

Download article (PDF)

Next Article In Issue>

Volume 26, Issue Supplement 1, December 2020, Pages S15 - S16

YI 2.3 Methylglyoxal, 3-Deoxyglucosone, and Glyoxal – Precursors of Advanced Glycation Endproducts – are not Independently Associated with Indices of Carotid Stiffness: The Maastricht Study

Authors

Myrthe van der Bruggen¹^{, 2}^{, *}, Marleen M.J. van Greevenbroek¹^{, 3}, Koen D. Reesink¹^{, 2}, Coen D.A. Stehouwer¹^{, 3}, Tammo Delhaas¹^{, 2}, Bart Spronck¹^{, 2}^{, 4}, Casper G. Schalkwijk¹^{, 3}

¹CARIM School for Cardiovascular Diseases, Maastricht University

²Department of Biomedical Engineering, Maastricht University

³Department of Internal Medicine, Maastricht University Medical Centre

⁴Department of Biomedical Engineering, School of Engineering & Applied Science, Yale University

^*Corresponding author. Email: m.vanderbruggen@maastrichtuniversity.nl

Corresponding Author

Myrthe van der Bruggen

Available Online 31 December 2020.

DOI

10.2991/artres.k.201209.011 How to use a DOI?

Keywords

Hyperglycemia; ultrasound; dicarbonyl; biomechanics

Abstract

Background: Arterial stiffness is a strong predictor of cardiovascular diseases and all-cause mortality [1]. Increased fasting plasma concentrations of highly reactive dicarbonyl compounds – methylglyoxal (MGO), 3-deoxyglucosone (3-DG), and/or glyoxal (GO) – may cause arterial stiffening via for mation of advanced glycation endproducts, triggering maladaptive responses in vascular tissue, e.g. elastin degradation and collagen cross-linking [2]. We assessed the cross-sectional associations between MGO, 3-DG, and GO concentrations with local carotid stiffness measures (distensibility coefficient (cDC), radius-wall thickness ratio (cRWT), pulse wave velocity (cPWV), and Young’s elastic modulus (cE) using standardized main variables.

Methods: Fasting dicarbonyl concentrations were determined by ultra-performance liquid chromatography tandem mass spectrometry in EDTA plasma collected from 2275 participants (age: 60 ± 8 years, mean ± SD; 49% women, 605 with type 2 diabetes mellitus) of the Maastricht Study [3], an observational, population-based cohort study. Cross-sectional associations were assessed using multivariable linear regression analysis adjusting for age, sex, mean arterial pressure (MAP), heart rate, lifestyle factors, and medication. Since arterial stiffness measures are intrinsically pressure dependent, we additionally assessed the associations with pressure-corrected counterparts [4], instead of statistically correcting for MAP.

Results: Fasting dicarbonyl concentrations were associated with arterial stiffening (smaller cDC; larger cPWV and cE) in most crude models, but not in adjusted models (Table). cRWT was associated with 3-DG, but only in the crude model. The use of pressure-corrected metrics did not materially change the final models.

Model		cDC	cRWT	cPWV	cE
Model		α (95% CI)	α (95% CI)	α (95% CI)	α (95% CI)
MGO	0	–0.104(–0.145;–0.063)	0.011(–0.030;0.052)	0.103(0.062;0.144)	0.099(0.059;0.140)
	1	–0.032(–0.070;0.005)	0.010(–0.032;0.052)	0.032(–0.006;0.071)	0.033(–0.007;0.072)
	2	0.005(–0.029;0.039)	0.000(–0.042;0.042)	–0.004(–0.039;0.030)	–0.006(–0.042;0.030)
	3	0.003(–0.031;0.037)	0.000(–0. 043; 0.042)	–0.003(–0.038;0.032)	–0.005(–0.040;0.031)
3-DG	0	–0.164(–0.205;–0.123)	0.067(0.026;0.108)	0.149(0.108;0.190)	0.171(0.131;0.212)
	1	–0.102(–0.154;–0.051)	0.024(–0. 033; 0.082)	0.075(0.023;0.127)	0.093(0.039;0.147)
	2	–0.037(–0.084;0.009)	0.009(–0.049;0.066)	0.012(–0.036;0.060)	0.027(–0.023;0.076)
	3	–0.018(–0.065;0.029)	–0. 004(–0.062; 0.054)	–0.007(–0.056;0.041)	0.004(–0.045;0.054)
GO	0	–0.054(–0.095;–0.013)	–0.032(–0.074;0.009)	0.054(0.012;0.095)	0.038(–0.003;0.079)
	1	–0.015(–0.051;0.022)	–0.014(–0.055; 0.026)	0.015(–0.022;0.052)	0.008(–0.030;0.046)
	2	0.002(–0.031;0.035)	–0.015(–0.056;0.025)	–0.002(–0.035;0.032)	–0.008(–0. 042;0. 027)
	3	–0.009(–0.042;0.024)	–0.013(–0.053; 0.028)	0.011(–0.022;0.045)	0.005(–0.030;0.040)

Model 0: crude associations. Model 1: model 0 + age, sex, and glucose metabolism status. Model 2: model 1 + mean arterial pressure and mean heart rate, and anti-hypertensive drugs. Model 3: model 2 + body mass index, smoking status, physical activity, use of lipid-modifying drugs, fasting triglycerides and total-to-high-density lipoprotein cholesterol levels, alcohol use, history of cardiovascular disease, kidney function, and Dutch healthy diet score. MGO, methylglyoxal; 3DG, 3-deoxyglucosone; GO, glyoxal; cDC, carotid distensibility coefficient; cRWT, carotid radius-wall thickness ratio; cPWV, carotid pulse wave velocity; cE, carotid Young’s elastic modulus. Significant associations (p < 0.05) printed in bold.

Table

Associations between fasting plasma dicarbonyls and carotid stiffness measures

Conclusion: Fasting plasma concentrations of either MGO, 3-DG, or GO are not independently associated with carotid stiffness in this cross-sectional analysis.

Copyright

Open Access

This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

REFERENCES

[1]K Sutton-Tyrrell, SS Najjar, RM Boudreau, L Venkitachalam, V Kupelian, EM Simonsick, et al., Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults, Circulation, Vol. 111, 2005, pp. 3384-90.

[2]CG Schalkwijk and CDA Stehouwer, Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases, Physiol Rev, Vol. 100, 2020, pp. 407-61.

[3]MT Schram, SJS Sep, CJ van der Kallen, PC Dagnelie, A Koster, N Schaper, et al., The Maastricht study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities, Eur J Epidemiol, Vol. 29, 2014, pp. 439-51.

[4]S Bos, RM Bruno, B Spronck, M Heusinkveld, S Taddei, L Ghiadoni, et al., Blood pressure lowering halts carotid artery stiffening in hypertensive patients: the CATOD study, Artery Res, Vol. 20, 2017, pp. 71-2.

<Previous Article In Issue

Download article (PDF)

Next Article In Issue>

Journal: Artery Research
Volume-Issue: 26 - Supplement 1
Pages: S15 - S16
Publication Date: 2020/12/31
ISSN (Online): 1876-4401
ISSN (Print): 1872-9312
DOI: 10.2991/artres.k.201209.011 How to use a DOI?
Open Access: This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

ris enw bib

TY  - JOUR
AU  - Myrthe van der Bruggen
AU  - Marleen M.J. van Greevenbroek
AU  - Koen D. Reesink
AU  - Coen D.A. Stehouwer
AU  - Tammo Delhaas
AU  - Bart Spronck
AU  - Casper G. Schalkwijk
PY  - 2020
DA  - 2020/12/31
TI  - YI 2.3 Methylglyoxal, 3-Deoxyglucosone, and Glyoxal – Precursors of Advanced Glycation Endproducts – are not Independently Associated with Indices of Carotid Stiffness: The Maastricht Study
JO  - Artery Research
SP  - S15
EP  - S16
VL  - 26
IS  - Supplement 1
SN  - 1876-4401
UR  - https://doi.org/10.2991/artres.k.201209.011
DO  - 10.2991/artres.k.201209.011
ID  - vanderBruggen2020
ER  -

download .riscopy to clipboard